Herpesvirus 8 IgG Antibody IFA
Use
Human herpesvirus‑8 (HHV‑8), also known as Kaposi’s Sarcoma‑associated Herpesvirus (KSHV), is associated with Kaposi’s sarcoma (KS), including classic and AIDS‑related forms, and also some B‑cell lymphomas. IgG antibodies are found in >80 % of KS patients and about 30 % of HIV‑seropositive persons without KS, whereas <5 % of healthy blood donors exhibit detectable IgG against HHV‑8.
Special Instructions
Not provided.
Limitations
This test was developed by Quest Diagnostics and its analytical performance characteristics have been determined by Quest. It has not been cleared or approved by the FDA. The assay has been validated under CLIA regulations and is used for clinical testing.
Methodology
Immunoassay (IFA)
Biomarkers
HHV‑8 IgG Antibody
Analyte
Result Turnaround Time
2-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
0.1 mL
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant